Cue Biopharma, Inc.
CUENasdaqCIK 1645460HealthcareFiscal year ends Dec 31
Reports and events: 146 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2112:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-396094 |
| 2026-08-2120:55 ET | SCHEDULE 13D | Ownership report, active investor | 0001725092-26-000015 |
| 2026-08-1420:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-352128 |
| 2026-08-1420:00 ET | 8-K | 2.02 Results of operations | 0001193125-26-352126 |
| 2026-08-0320:47 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-330730 |
| 2026-07-1021:29 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-301052 |
| 2026-06-0320:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-255479 |
| 2026-06-0220:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-26-253709 |
| 2026-05-2112:51 ET | DEF 14A | Proxy statementPeriod 2026-06-01 | 0001193125-26-233369 |
| 2026-05-1420:19 ET | 8-K | 9.01 Financial statements and exhibits | 0001193125-26-224101 |
| 2026-05-1420:18 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-224091 |
| 2026-05-0100:42 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-198588 |
| 2026-04-2212:47 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws | 0001193125-26-168907 |
| 2026-04-1320:00 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-152826 |
| 2026-04-0712:00 ET | 8-K | 8.01 Other events | 0001193125-26-144569 |
| 2026-03-2720:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-128993 |
| 2026-03-1620:01 ET | DEF 14A | Proxy statementPeriod 2026-03-16 | 0001193125-26-108301 |
| 2026-03-1620:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-108292 |
| 2026-03-1620:00 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-108287 |
| 2026-02-1821:00 ET | 8-K | 8.01 Other events | 0001193125-26-056983 |
| 2026-02-1213:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-047717 |
| 2025-12-1921:22 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-326925 |
| 2025-11-2413:08 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-25-292093 |
| 2025-11-2021:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-289713 |
| 2025-11-1221:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-277466 |
| 2025-11-1221:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-277468 |
| 2025-11-0613:03 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-268135 |
| 2025-09-2920:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950130-25-000140 |
| 2025-08-1220:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-107270 |
| 2025-08-1220:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-107268 |
| 2025-07-0120:00 ET | 8-K | 1.01 Entry into a material agreement | 0000950170-25-092168 |
| 2025-06-1020:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-084279 |
| 2025-05-1220:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-069125 |
| 2025-05-1220:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069124 |
| 2025-04-2520:00 ET | DEF 14A | Proxy statementPeriod 2025-06-03 | 0000950170-25-058681 |
| 2025-04-1520:48 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-081592 |
| 2025-04-1421:03 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-25-080277 |
| 2025-03-3120:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-047678 |
| 2025-03-3120:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-047677 |
| 2025-03-1220:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-037885 |
| 2024-11-1421:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-127005 |
| 2024-11-1421:00 ET | 8-K | 2.02 Results of operations | 0000950170-24-127004 |
| 2024-10-0820:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-113520 |
| 2024-10-0420:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-112887 |
| 2024-09-2720:17 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-227977 |
| 2024-09-1020:00 ET | DEF 14A | Proxy statementPeriod 2024-10-08 | 0000950170-24-105104 |
| 2024-09-0320:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-102851 |
| 2024-08-1620:00 ET | 8-K | 3.01 Delisting notice | 0000950170-24-098032 |
| 2024-08-1420:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-096967 |
| 2024-07-2520:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-086476 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.